NCT05313698 is a clinical trial of No intervention in Cerebral Palsy, sponsored by Muş Alparslan University.

Who is sponsoring NCT05313698?

NCT05313698 is sponsored by Muş Alparslan University.

What drugs are being tested in NCT05313698?

Interventions in NCT05313698: No intervention.

What condition does NCT05313698 study?

NCT05313698 studies Cerebral Palsy.

Is NCT05313698 still recruiting?

NCT05313698 is currently completed. Last updated 3 June 2022.

Last reviewed 2022-06-03 · How we verify

NCT05313698

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validity and Reliability of The Turkish Version of The Kidscreen-27

Completed Last updated 3 June 2022

What this trial tests

trial testing No intervention in Cerebral Palsy in 135 participants. Completed in 1 May 2022.

Timeline

1 January 2022

Primary endpoint
1 April 2022

1 May 2022

Quick facts

Lead sponsor	Muş Alparslan University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	135
Start date	1 January 2022
Primary completion	1 April 2022
Estimated completion	1 May 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

No intervention

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →

Sponsor

Muş Alparslan University

Who can join

Adults 8 to 18, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Functional impairment of the upper extremities can impair the health-related quality of life (HRQOL) of persons with Cerebral Palsy CP. Health-related quality of life (HRQOL) measures several subjective dimensions dealing with the impact of health or illness on physical and psychosocial functioning. Quality of life (QOL) measures for children and adolescents have been developed in recent years, initially for children with specific chronic conditions, but more recently generic and health-related QOL (HRQOL) measures have been developed . The early assessments of children's quality of life were mostly disease-specific, and this trend has continued. Generic HRQOL measurements for children and adolescents can help identify subgroups of children and adolescents who are at risk of developing health problems. KIDSCREEN-27 is a generic HRQOL measure derived from KIDSCREEN-52. The KIDSCREEN-27 is a subset of the KIDSCREEN-52 that includes 27 items for assessing HRQOL across five dimensions: Physical Well-Being (5 items) examines a child's or adolescent's level of physical activity, energy, and fitness. Although the psychometric properties of the Turkish version of the KIDSCREEN forms have been studied previously; however, its psychometric characteristics in children with CP have yet to be determined. Accordingly, the aim of this study is to provide an overview of the psychometric results of the KIDSCREEN-27 HRQOL questionnaire

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Other Muş Alparslan University trials

Trials by the same sponsor.

NCT07507695 — Acute Effects of Patellar Tendon Ultrasound on Countermovement Jump Performance · NA · not yet recruiting
NCT07297628 — Teaching Caring Through '1 Concept-1 Minute · NA · not yet recruiting
NCT07397221 — Oropharyngeal Humidification After Extubation on Thirst · NA · not yet recruiting
NCT07355244 — Self-Affirmation Intervention After Mastectomy · NA · not yet recruiting
NCT07274553 — Mindfulness-Based Stress Reduction for Adolescents: Effects on Game Addiction, Stress, and Sleep · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05313698 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Muş Alparslan University
Last refreshed: 3 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05313698.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing